• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of longitudinal Aβ in nondemented elderly and Down syndrome.比较非痴呆老年人与唐氏综合征患者的纵向 Aβ。
Neurobiol Aging. 2019 Jan;73:171-176. doi: 10.1016/j.neurobiolaging.2018.09.030. Epub 2018 Sep 27.
2
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
3
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
4
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations.与神经正常人群相比,正电子发射断层扫描(PET)测量显示,唐氏综合征患者大脑中β淀粉样蛋白的积累速度加快。
Alzheimers Dement. 2025 Jun;21(6):e70357. doi: 10.1002/alz.70357.
5
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
6
Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.唐氏综合征健康成年人的认知功能与脑淀粉样β蛋白的关系
Brain. 2014 Sep;137(Pt 9):2556-63. doi: 10.1093/brain/awu173. Epub 2014 Jul 2.
7
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.
8
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.用碳11标记的匹兹堡化合物B成像,正常衰老对非痴呆唐氏综合征成年人β淀粉样蛋白沉积的影响。
Alzheimers Dement. 2016 Apr;12(4):380-90. doi: 10.1016/j.jalz.2015.05.013. Epub 2015 Jun 13.
9
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.与 APP 双突变和唐氏综合征家族性阿尔茨海默病相关的脑淀粉样血管病的淀粉样-β肽特征。
Acta Neuropathol. 2024 Jul 18;148(1):8. doi: 10.1007/s00401-024-02756-4.
10
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments.唐氏综合征和临床前阿尔茨海默病中β-淀粉样蛋白和tau病理的联合空间关联:与早期认知障碍的横断面关联
Alzheimers Dement. 2025 Jul;21(7):e70424. doi: 10.1002/alz.70424.

引用本文的文献

1
Age and sex are associated with Alzheimer's disease neuropathology in Down syndrome.年龄和性别与唐氏综合征中的阿尔茨海默病神经病理学相关。
Alzheimers Dement. 2025 Jul;21(7):e70408. doi: 10.1002/alz.70408.
2
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments.唐氏综合征和临床前阿尔茨海默病中β-淀粉样蛋白和tau病理的联合空间关联:与早期认知障碍的横断面关联
Alzheimers Dement. 2025 Jul;21(7):e70424. doi: 10.1002/alz.70424.
3
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations.与神经正常人群相比,正电子发射断层扫描(PET)测量显示,唐氏综合征患者大脑中β淀粉样蛋白的积累速度加快。
Alzheimers Dement. 2025 Jun;21(6):e70357. doi: 10.1002/alz.70357.
4
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: Comparison of two radiotracers.在唐氏综合征中,纹状体是使用[C]PiB检测淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较。
Alzheimers Dement. 2025 Apr;21(4):e70141. doi: 10.1002/alz.70141.
5
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: comparison of two radiotracers.纹状体是唐氏综合征中使用[C]匹兹堡化合物B(PiB)检测淀粉样蛋白负荷的早期准确指标:两种放射性示踪剂的比较。
medRxiv. 2024 Dec 6:2024.12.04.24318526. doi: 10.1101/2024.12.04.24318526.
6
Characterizing the emergence of amyloid and tau burden in Down syndrome.描述唐氏综合征中淀粉样蛋白和tau 负担的出现。
Alzheimers Dement. 2024 Jan;20(1):388-398. doi: 10.1002/alz.13444. Epub 2023 Aug 29.
7
Alzheimer's disease associated with Down syndrome: a genetic form of dementia.唐氏综合征相关的阿尔茨海默病:一种遗传性痴呆。
Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.
8
Postmortem Neocortical H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer's Disease.唐氏综合征和散发性阿尔茨海默病患者死后新皮层H-PiB结合以及未修饰和焦谷氨酸化β-淀粉样蛋白水平
Front Aging Neurosci. 2021 Aug 13;13:728739. doi: 10.3389/fnagi.2021.728739. eCollection 2021.
9
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.基底前脑胆碱能神经元:连接唐氏综合征与阿尔茨海默病
Front Aging Neurosci. 2021 Jul 12;13:703876. doi: 10.3389/fnagi.2021.703876. eCollection 2021.
10
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.PET 测量纵向淀粉样蛋白负荷可在唐氏综合征阿尔茨海默病进展过程中识别淀粉样β 聚集的最早阶段。
Neuroimage. 2021 Mar;228:117728. doi: 10.1016/j.neuroimage.2021.117728. Epub 2021 Jan 7.

本文引用的文献

1
PET staging of amyloidosis using striatum.使用纹状体进行淀粉样变性的 PET 分期。
Alzheimers Dement. 2018 Oct;14(10):1281-1292. doi: 10.1016/j.jalz.2018.04.011. Epub 2018 May 21.
2
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.早期纹状体淀粉样蛋白沉积可将唐氏综合征和常染色体显性阿尔茨海默病与晚发性淀粉样蛋白沉积区分开来。
Alzheimers Dement. 2018 Jun;14(6):743-750. doi: 10.1016/j.jalz.2018.01.002. Epub 2018 Mar 1.
3
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population.非痴呆唐氏综合征人群中淀粉样蛋白正电子发射断层扫描和容积磁共振成像的纵向变化。
Alzheimers Dement (Amst). 2017 May 23;9:1-9. doi: 10.1016/j.dadm.2017.05.001. eCollection 2017.
4
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.50-95岁认知未受损个体中脑β淀粉样变性、tau蛋白病和神经退行性变的年龄及性别特异性患病率:一项横断面研究
Lancet Neurol. 2017 Jun;16(6):435-444. doi: 10.1016/S1474-4422(17)30077-7. Epub 2017 Apr 26.
5
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
6
Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE.通过对纵向可靠性、合理性、可分离性以及与简易精神状态检查表(MMSE)的相关性进行大规模分析,优化匹兹堡化合物B正电子发射断层扫描(PiB-PET)标准化摄取值比率(SUVR)随时间变化的测量。
Neuroimage. 2017 Jan 1;144(Pt A):113-127. doi: 10.1016/j.neuroimage.2016.08.056. Epub 2016 Aug 27.
7
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.唐氏综合征中的衰老与阿尔茨海默病神经病理学的发展
Curr Alzheimer Res. 2016;13(1):18-29. doi: 10.2174/1567205012666151020114607.
8
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.用碳11标记的匹兹堡化合物B成像,正常衰老对非痴呆唐氏综合征成年人β淀粉样蛋白沉积的影响。
Alzheimers Dement. 2016 Apr;12(4):380-90. doi: 10.1016/j.jalz.2015.05.013. Epub 2015 Jun 13.
9
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.通过脑白质参考区域增强纵向淀粉样蛋白β正电子发射断层扫描(PET)变化特征描述及评估淀粉样蛋白修饰治疗的效能。
J Nucl Med. 2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5.
10
Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.采用基于白质参照和基于感兴趣区的部分容积效应校正的方法改善纵向 [(18)F]-AV45 淀粉样 PET 成像。
Neuroimage. 2015 Mar;108:450-9. doi: 10.1016/j.neuroimage.2014.11.055. Epub 2014 Dec 4.

比较非痴呆老年人与唐氏综合征患者的纵向 Aβ。

Comparison of longitudinal Aβ in nondemented elderly and Down syndrome.

机构信息

Department of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA.

Department of Biostatistics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA.

出版信息

Neurobiol Aging. 2019 Jan;73:171-176. doi: 10.1016/j.neurobiolaging.2018.09.030. Epub 2018 Sep 27.

DOI:10.1016/j.neurobiolaging.2018.09.030
PMID:30359879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6251757/
Abstract

Down syndrome (DS) predisposes individuals to early Alzheimer's disease (AD). Using Pittsburgh Compound B ([C]PiB), a pattern of striatal amyloid beta (Aβ) that is elevated relative to neocortical binding has been reported, similar to that of nondemented autosomal dominant AD mutation carriers. However, it is not known whether changes in striatal and neocortical [C]PiB retention differ over time in a nondemented DS population when compared to changes in a nondemented elderly (NDE) population. The purpose of this work was to assess longitudinal changes in trajectories of Aβ in a nondemented DS compared to an NDE cohort. The regional trajectories for anterior ventral striatum (AVS), frontal cortex, and precuneus [C]PiB retention were explored over time using linear mixed effects models with fixed effects of time, cohort, and time-by-cohort interactions and subject as random effects. Significant differences between DS and NDE cohort trajectories for all 3 region of interests were observed (p < 0.05), with the DS cohort showing a faster accumulation in the AVS and slower accumulation in the frontal cortex and precuneus compared to the NDE cohort. These data add to the previously reported distinct pattern of early striatal deposition not commonly seen in sporadic AD by demonstrating that individuals with DS may also accumulate Aβ at a rate faster in the AVS when compared to NDE subjects.

摘要

唐氏综合征(DS)使个体易患早发性阿尔茨海默病(AD)。使用匹兹堡化合物 B([C]PiB),已经报道了纹状体淀粉样β(Aβ)的模式,其相对于新皮层结合升高,类似于非痴呆常染色体显性 AD 突变携带者。然而,当与非痴呆老年(NDE)人群相比,在非痴呆 DS 人群中,纹状体和新皮层[C]PiB 保留的变化是否随时间而不同尚不清楚。这项工作的目的是评估与 NDE 队列相比,在非痴呆 DS 中 Aβ的轨迹随时间的纵向变化。使用线性混合效应模型,使用时间、队列和时间-队列相互作用的固定效应以及受试者作为随机效应,探索了前腹侧纹状体(AVS)、额叶皮层和楔前叶[C]PiB 保留的区域轨迹。观察到所有 3 个感兴趣区域的 DS 和 NDE 队列轨迹之间存在显著差异(p<0.05),与 NDE 队列相比,DS 队列在 AVS 中的积累速度更快,而在额叶皮层和楔前叶中的积累速度更慢。这些数据通过证明与 NDE 受试者相比,DS 个体在 AVS 中也可能以更快的速度积累 Aβ,补充了先前报道的早期纹状体沉积的独特模式,这在散发性 AD 中通常不会见到。